(Q39169766)

9 September 2017

New approaches to antibiotic discovery (English)

1 reference

9 September 2017

C Kealey

1

1 reference

9 September 2017

C A Creaven

series ordinal

2

1 reference

9 September 2017

C D Murphy

series ordinal

3

1 reference

9 September 2017

C B Brady

series ordinal

4

1 reference

9 September 2017

8 March 2017

1 reference

9 September 2017

Biotechnology Letters

1 reference

9 September 2017

39

1 reference

9 September 2017

805-817

1 reference

9 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s10529-017-2311-8

9 September 2017

0 references

cites work

Actinomycetes from Red Sea sponges: sources for chemical and phylogenetic diversity

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Pharmacodynamics, pharmacokinetics and clinical efficacy of telavancin in the treatment of pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Mechanism of action of oritavancin and related glycopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Microbiological effects of sublethal levels of antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Renaissance in antibacterial discovery from actinomycetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Genomic analyses lead to novel secondary metabolites. Part 3. ECO-0501, a novel antibacterial of a new class.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Isolation and identification of three new 5-alkenyl-3,3(2H)-furanones from two streptomyces species using a genomic screening approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Thoughts and facts about antibiotics: where we are now and where we are heading

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Tackling antibiotic resistance: the environmental framework.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Regulation of fungal secondary metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Antibiotics in the clinical pipeline at the end of 2015.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Efficacy of surotomycin in an in vitro gut model of Clostridium difficile infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Endophytic bacteria as a source of novel antibiotics: An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Origins and evolution of antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Antibiotic resistance is ancient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

The Future of Antibiotics: Emerging Technologies and Stewardship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Lassomycin, a Ribosomally Synthesized Cyclic Peptide, Kills Mycobacterium tuberculosis by Targeting the ATP-Dependent Protease ClpC1P1P2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Isolation of antibiotics turbomycin a and B from a metagenomic library of soil microbial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Rethinking the Antibiotic Discovery Paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Clinical development success rates for investigational drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Warkmycin, a novel angucycline antibiotic produced by Streptomyces sp. Acta 2930*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Bio-mining the microbial treasures of the ocean: new natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Natural products: untwisting the antibiotic'ome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Isolating "uncultivable" microorganisms in pure culture in a simulated natural environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

NMR-based plant metabolomics: where do we stand, where do we go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Antibiotic resistance-the need for global solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Platforms for antibiotic discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

A new antibiotic kills pathogens without detectable resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Genome mining reveals unlocked bioactive potential of marine Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Diversity and antibacterial activity of bacteria isolated from the coastal marine sponges Amphilectus fucorum and Eurypon major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Microbial genomics as a guide to drug discovery and structural elucidation: ECO-02301, a novel antifungal agent, as an example.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Escherichia coli Harboring mcr-1 and bla CTX-M on a Novel IncF Plasmid: First Report of mcr-1 in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Natural Products as a Source for Novel Antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Use of ichip for high-throughput in situ cultivation of "uncultivable" microbial species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Enabling techniques in the search for new antibiotics: Combinatorial biosynthesis of sugar-containing antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Isolation and characterization of multifunctional Streptomyces species with antimicrobial, nematicidal and phytohormone activities from marine environments in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Optimization and production of novel antimicrobial agents from sponge associated marine actinomycetes Nocardiopsis dassonvillei MAD08.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Exploiting the genome sequence of Streptomyces nodosus for enhanced antibiotic production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Biotechnological potential of endophytic actinomycetes associated with Asteraceae plants: isolation, biodiversity and bioactivities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Identifying producers of antibacterial compounds by screening for antibiotic resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

ESKAPEing the labyrinth of antibacterial discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Antibiotics in microbial coculture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

The Sequence of the Human Genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Novel natural products from soil DNA libraries in a streptomycete host

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

New antibiotics from Nature's chemical inventory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Metagenomic approaches for exploiting uncultivated bacteria as a resource for novel biosynthetic enzymology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

An environmental bacterial taxon with a large and distinct metabolic repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Combinatorial biosynthesis of polyketides--a perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Q&A: antibiotic resistance: what more do we know and what more can we do?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Metabolomics in the natural products field--a gateway to novel antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

Metabolomics: Current analytical platforms and methodologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-017-2311-8

10.1007/S10529-017-2311-8

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference